GENEVA, Aug. 31 -- UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. filed a patent application (US2026/016218) for “SYNTHESIS AND ANTIVIRAL ACTIVITY OF DIOXOLANE-DERIVED 7-DEAZAPURINE NUCLEOSIDE ANALOGS AND METHODS OF TREATING EPSTEIN BARR VIRUS (EBV) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTIONS”. With publication no. WO/2026/178472, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 473/16
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....